Your browser doesn't support javascript.
loading
[Myeloid sarcomas of the shoulder and testis relapsing 9 years after allogenic stem cell transplantation for acute myeloid leukemia].
Yamamoto, Rikuo; Suyama, Takuya; Yoshizawa, Yuki; Shimizu, Misayo; Kuroda, Akihiro; Shinagawa, Atsushi.
Afiliação
  • Yamamoto R; Hematology and Oncology Division, Hitachi General Hospital.
  • Suyama T; Hematology and Oncology Division, Hitachi General Hospital.
  • Yoshizawa Y; Hematology and Oncology Division, Hitachi General Hospital.
  • Shimizu M; Hematology and Oncology Division, Hitachi General Hospital.
  • Kuroda A; Hematology and Oncology Division, Hitachi General Hospital.
  • Shinagawa A; Hematology and Oncology Division, Hitachi General Hospital.
Rinsho Ketsueki ; 63(8): 860-864, 2022.
Article em Ja | MEDLINE | ID: mdl-36058855
ABSTRACT
This report describes a 56-year-old man who was diagnosed with myeloid sarcoma (MS) of the testis and right shoulder after receiving allogenic stem cell transplantation (allo-SCT) at the age of 47 for acute myeloid leukemia (AML) with inv (16) (p13.1;q22). Nine years after allo-SCT, he complained of a painful right testicular mass. He underwent orchiectomy, and the pathologic diagnosis was MS. Inv (16) was identified by fluorescence in situ hybridization (FISH) using testicular tumor specimens. 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) revealed FDG accumulation in the right shoulder. FISH analysis of bone marrow aspirate revealed no increase in blasts and ruled out CBFB-MYH11 fusion. Reinduction chemotherapy, consolidation, and local radiation therapy for the left testis and right shoulder were administered to him. After that, he received a second allo-SCT from an unrelated donor who was HLA-matched. As of 2 years after the second allo-SCT, recurrence of neither AML nor myeloid sarcoma has been observed. The recurrence of MSs without bone marrow involvement is frequently reported in single, multiple single organs, or multiple single regions. Even if MSs recur in a distant location, combining systemic and local treatment may be a better treatment strategy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Sarcoma Mieloide Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Humans / Male Idioma: Ja Revista: Rinsho Ketsueki Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Sarcoma Mieloide Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Humans / Male Idioma: Ja Revista: Rinsho Ketsueki Ano de publicação: 2022 Tipo de documento: Article